New data finds an experimental cancer treatment is showing major promise. Our team spoke with the first person to receive a ...

This week on "The Readout LOUD," a pancreatic cancer breakthrough and new hope for an off-the-shelf CAR-T treatment in ...

Daraxonrasib, a new pancreatic cancer drug, cut the risk of death by 60% in a Phase 3 trial. A doctor explains how it works, ...

New findings support hypothesis that current nanoparticle designed for pancreatic and liver cancers could also work for colorectal cancerLehi, Utah, April 16, 2026 (GLOBE NEWSWIRE) -- CancerVax, Inc., ...

CLEVELAND, Ohio — The benefits of getting regular exercise, combining two cancer drugs with chemotherapy, and using AI to screen blood for signs of colorectal cancer were among the newest developments ...

New experimental medications seem to extend survival with the hard-to-treat cancer.

These results indicate that the inexpensive and safe off-label applications of these medications could be an important ...

Cancer survival rates are on the rise, according to the American Cancer Society's latest annual report. Seven in 10 patients now live five years or more after a cancer diagnosis. Since 1991, ...

Promising new research suggests a triple threat approach could help treat pancreatic cancer. Researchers in Spain have developed a new therapy protocol that could revolutionize the treatment of ...

A new review from the Icahn School of Medicine at Mount Sinai and the Hospital Clínic de Barcelona provides one of the clearest roadmaps to date for understanding and treating liver cancer, one of the ...

Novel blood-based biomarker predicts cancer risk in patients with Lynch Syndrome New epigenetic target sensitizes pancreatic tumors to immunotherapy Promising strategy may help to overcome radiotherap ...

A £6.9m clinical trial programme that aims to improve brain cancer treatment for patients in Yorkshire has been launched by a ...